214 related articles for article (PubMed ID: 35216717)
21. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review.
Rohman L
Eat Disord; 2009; 17(3):187-99. PubMed ID: 19391018
[TBL] [Abstract][Full Text] [Related]
22. Anabolic steroid-induced hypogonadism--towards a unified hypothesis of anabolic steroid action.
Tan RS; Scally MC
Med Hypotheses; 2009 Jun; 72(6):723-8. PubMed ID: 19231088
[TBL] [Abstract][Full Text] [Related]
23. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
[TBL] [Abstract][Full Text] [Related]
24. Testicular morphology in hypogonadotropic hypogonadism after the abuse of anabolic steroids.
Alibegović A
Forensic Sci Med Pathol; 2018 Dec; 14(4):564-567. PubMed ID: 30175397
[TBL] [Abstract][Full Text] [Related]
25. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
[No Abstract] [Full Text] [Related]
26. Anabolic steroids and male infertility: a comprehensive review.
de Souza GL; Hallak J
BJU Int; 2011 Dec; 108(11):1860-5. PubMed ID: 21682835
[TBL] [Abstract][Full Text] [Related]
27. The deleterious effects of anabolic androgenic steroid abuse on sexual and reproductive health and comparison of recovery between treated and untreated patients: Single-center prospective randomized study.
Al Hashimi M
Andrologia; 2022 Dec; 54(11):e14576. PubMed ID: 36065528
[TBL] [Abstract][Full Text] [Related]
28. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
[TBL] [Abstract][Full Text] [Related]
29. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse.
Tan RS; Vasudevan D
Fertil Steril; 2003 Jan; 79(1):203-5. PubMed ID: 12524089
[TBL] [Abstract][Full Text] [Related]
30. Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors.
de Zeeuw TI; Brunt TM; van Amsterdam J; van de Ven K; van den Brink W
Eur Addict Res; 2023; 29(2):99-108. PubMed ID: 36731448
[TBL] [Abstract][Full Text] [Related]
31. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.
Henriksen HCB; Havnes IA; Jørstad ML; Bjørnebekk A
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):19. PubMed ID: 37013635
[TBL] [Abstract][Full Text] [Related]
32. [Anabolic steroid induced hypogonadism in men: overview and case report].
Stárka L; Dušková M; Kolátorová L; Lapčík O
Vnitr Lek; 2017; 63(9):598-603. PubMed ID: 29120657
[TBL] [Abstract][Full Text] [Related]
33. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters.
Scarth M; Westlye LT; Havnes IA; Bjørnebekk A
BMC Psychiatry; 2023 May; 23(1):342. PubMed ID: 37193971
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study.
Kanayama G; Pope HG; Cohane G; Hudson JI
Drug Alcohol Depend; 2003 Jul; 71(1):77-86. PubMed ID: 12821208
[TBL] [Abstract][Full Text] [Related]
35. The Health Threat Posed by the Hidden Epidemic of Anabolic Steroid Use and Body Image Disorders Among Young Men.
Goldman AL; Pope HG; Bhasin S
J Clin Endocrinol Metab; 2019 Apr; 104(4):1069-1074. PubMed ID: 30239802
[TBL] [Abstract][Full Text] [Related]
36. [Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users].
Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):339-344. PubMed ID: 35473320
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and Management of Anabolic Androgenic Steroid Use.
Anawalt BD
J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
[TBL] [Abstract][Full Text] [Related]
38. Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study.
van Breda E; Keizer HA; Kuipers H; Wolffenbuttel BH
Int J Sports Med; 2003 Apr; 24(3):195-6. PubMed ID: 12740738
[TBL] [Abstract][Full Text] [Related]
39. Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.
Bonnecaze AK; O'Connor T; Burns CA
J Gen Intern Med; 2021 Jul; 36(7):2055-2064. PubMed ID: 33948794
[TBL] [Abstract][Full Text] [Related]
40. Anabolic androgenic steroids: a survey of 500 users.
Parkinson AB; Evans NA
Med Sci Sports Exerc; 2006 Apr; 38(4):644-51. PubMed ID: 16679978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
